Drug interactions
Alogliptin-metformin + Pacritinib
Severity: Moderate
Alogliptin-metformin and Pacritinib: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Pacritinib inhibits OCT1, which mediates hepatic uptake of metformin and may alter its exposure and effect.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Alogliptin-metformin and Pacritinib interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Alogliptin-metformin
Drug class
- Alogliptin-metformin
- Endocrine
- Pacritinib
- Oncology
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
